Liquid Chromatography development for determination of ebastine in pharma
May 12 2011 Comments 0
The news source reported that this model depends on the complexation ability of the studied drug with Zn2+ ions.
Reversed phase chromatography was carried out using an ODS c18 stainless steel column with UV-detection at 260nm.
Furthermore, a mobile phase containing 0.025 per cent w/v Zn2+ in a mixture of (acetonitril/methanol) and Britton Robinson buffer, which was adjusted to a pH of 4.2, was used to determine the ebastine at a flow rate of one ml/min.
It was also reported that content uniformity testing of the method was also conducted, while the make-up of the complex and its stability constant was looked into.
Recently, liquid chromatography was used to analyse endometrial hyperplasia and carcinoma, with findings published in the Journal of Hematology and Oncology, highlighting that these gynaecological malignancies are the most common.
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In this issue: FUNDAMENTAL ASPECTS Development and Comparison of Quantitative Methods Using Orthogonal Chromatographic Techniques for the Analysis of Potential Mutagenic Impurities Develop...
View all digital editions
Jul 25 2017 Loughborough, UK
Aug 07 2017 Rome, Italy
Aug 21 2017 Lausanne, Switzerland
Aug 28 2017 Stockholm, Sweden
Sep 04 2017 Birmingham, UK